CIK 0000885725 · Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042695240
- Phone
- 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-30 | Mahoney Michael F Chairman, President & CEO | Gift | −149,992 | 213,679 | ||
| 2025-10-29 | Mahoney Michael F Chairman, President & CEO | Gift | +88,197 | 289,675 | ||
| 2025-10-29 | Mahoney Michael F Chairman, President & CEO | Gift | +73,996 | 363,671 | ||
| 2025-10-29 | Zane Ellen M Director | Other acquisition | +12,891 | 37,025 | ||
| 2025-10-28 | Zane Ellen M Director | Sale 10b5-1 | −2,901 | $102.24 | $297K | 24,134 |
| 2025-10-27 | Zane Ellen M Director | Sale 10b5-1 | −9,990 | $101.13 | $1.0M | 27,035 |
| 2025-10-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise 10b5-1 | +50,000 | $26.15 | $1.3M | 228,342 |
| 2025-10-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Sale 10b5-1 | −8,245 | $98.91 | $815K | 220,097 |
| 2025-10-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Sale 10b5-1 | −41,755 | $98.38 | $4.1M | 178,342 |
| 2025-10-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 50,000 | ||
| 2025-09-02 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise 10b5-1 | +50,000 | $26.15 | $1.3M | 228,342 |
| 2025-09-02 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Sale 10b5-1 | −21,830 | $104.89 | $2.3M | 206,512 |
| 2025-09-02 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Sale 10b5-1 | −28,170 | $105.85 | $3.0M | 178,342 |
| 2025-09-02 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 100,000 | ||
| 2025-08-02 | Monson Jonathan EVP and CFO | Option exercise | +1,090 | 35,817 | ||
| 2025-08-02 | Monson Jonathan EVP and CFO | Shares withheld for taxes | −528 | $105.41 | $56K | 35,289 |
| 2025-08-02 | Monson Jonathan EVP and CFO | Option exercise · Restricted Stock Units | −1,090 | 0 | ||
| 2025-08-01 | LUDWIG EDWARD J Director | Gift | −500 | 17,979 | ||
| 2025-08-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise 10b5-1 | +50,000 | $26.15 | $1.3M | 228,342 |
| 2025-08-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Sale 10b5-1 | −50,000 | $104.63 | $5.2M | 178,342 |
Page 11 of 40 · 791 trades